Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer
A group of 27 patients diagnosed with metastatic triple-negative breast cancer (mTNBC) was randomly distributed into two groups and underwent different lines of metronomic treatment (mCHT). The former group (N 14) received first-line mCHT and showed a higher overall survival rate than the second gro...
Main Authors: | Alice Ilari, Viola Cogliati, Noorhan Sherif, Emanuela Grassilli, Daniele Ramazzotti, Nicoletta Cordani, Giorgio Cazzaniga, Camillo Di Bella, Marialuisa Lavitrano, Marina Elena Cazzaniga, Maria Grazia Cerrito |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/2/272 |
Similar Items
-
Assessment of metronomic chemotherapy–induced DNA damage in peripheral blood leukocytes from canine mammary cancer patients using the alkaline comet assay
by: Lorena Elizabeth Chalco–Torres, et al.
Published: (2024-01-01) -
Metronomic Chemotherapy
by: Marina Elena Cazzaniga, et al.
Published: (2021-05-01) -
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows
by: Marina Elena Cazzaniga, et al.
Published: (2022-08-01) -
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation
by: Arianna Scagliotti, et al.
Published: (2022-11-01) -
Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything
by: Serena Capici, et al.
Published: (2022-07-01)